Trade

with

Actavis PLC
(NYSE: ACT)
AdChoices
232.11
+5.40
+2.38%
After Hours :
-
-
-

Open

228.79

Previous Close

226.71

Volume (Avg)

1.48M (2.42M)

Day's Range

227.06-233.50

52Wk Range

143.71-249.94

Market Cap.

59.90B

Dividend Rate ( Yield )

-

Beta

0.35

Shares Outstanding

264.26M

P/E Ratio (EPS)

588.24 (0.38)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 8.68B

    • Net Income

    • -750.40M

    • Market Cap.

    • 59.90B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 0.62

    • PEG (Price/Earnings Growth) Ratio

    • 0.77

    • Beta

    • 0.35

    • Forward P/E

    • 13.62

    • Price/Sales

    • 3.68

    • Price/Book Value

    • 6.19

    • Price/Cash flow

    • 20.16

      • EBITDA

      • 646.10M

      • Return on Capital %

      • 0.32

      • Return on Equity %

      • 0.94

      • Return on Assets %

      • 0.32

      • Book Value/Share

      • 36.63

      • Shares Outstanding

      • 264.26M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 268.40

        • Credit Rating

        • BBB

        • Analysts

        • 8

        • EPS Estimate

        • 10.02

        • Cashflow Estimate

        • 19.52

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 34.00

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 27.90

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 49.15

            • 64.72

            • Pre-Tax Margin

            • 1.82

            • 13.77

            • Net Profit Margin

            • 0.62

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 43.90

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 5.30

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 2.40

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.11

              • 0.33

              • Current Ratio

              • 1.98

              • 1.52

              • Quick Ratio

              • 1.40

              • 0.87

              • Interest Coverage

              • 1.65

              • 6.77

              • Leverage Ratio

              • 2.66

              • 1.91

              • Book Value/Share

              • 36.63

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 588.24

                • 63.29

                • P/E Ratio 5-Year High

                • 657.70

                • 237.47

                • P/E Ratio 5-Year Low

                • 89.15

                • 19.71

                • Price/Sales Ratio

                • 3.65

                • 3.53

                • Price/Book Value

                • 6.13

                • 3.31

                • Price/Cash Flow Ratio

                • 20.16

                • 21.23

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 0.94

                    (2.70)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 0.32

                    (1.70)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 1.54

                    (1.10)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 3.25k

                  • 27.79k

                  • Inventory Turnover

                  • 3.18

                  • 1.80

                  • Asset Turnover

                  • 0.51

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -423.20M
                  Operating Margin
                  -4.88
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  20.16
                  Ownership

                  Institutional Ownership

                  69.88%

                  Top 10 Institutions

                  35.84%

                  Mutual Fund Ownership

                  36.37%

                  Float

                  99.55%

                  5% / Insider Ownership

                  0.45%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    4,321,700

                  • 5.94

                  • 1.64

                  • Vanguard Health Care Fund

                  •  

                    3,359,667

                  • -7.89

                  • 1.93

                  • Vanguard Five Hundred Index Fund

                  •  

                    2,743,477

                  • 0.12

                  • 1.04

                  • Vanguard Institutional Index Fund

                  •  

                    2,677,219

                  • -1.17

                  • 1.01

                  • SPDR® S&P 500 ETF

                  •  

                    2,635,591

                  • -1.10

                  • 0.93

                  • Fidelity® Contrafund® Fund

                  •  

                    2,342,021

                  • 2.21

                  • 0.89

                  • Fidelity® Select Health Care Portfolio

                  •  

                    2,180,000

                  • 4.81

                  • 0.82

                  • Vanguard Growth Index Fund

                  •  

                    1,299,709

                  • 5.44

                  • 0.49

                  • Health Care Select Sector SPDR® Fund

                  •  

                    1,223,136

                  • -5.00

                  • 0.43

                  • CREF Stock

                  •  

                    1,202,242

                  • -2.06

                  • 0.45

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity Management and Research Company

                  •  

                    16,594,609

                  • +2.28%

                  • 9.51

                  • Vanguard Group, Inc.

                  •  

                    9,021,418

                  • +3.43%

                  • 5.17

                  • State Street Corp

                  •  

                    8,616,895

                  • +25.38%

                  • 4.94

                  • Wellington Management Company, LLP

                  •  

                    8,471,877

                  • +9.27%

                  • 4.85

                  • BlackRock Fund Advisors

                  •  

                    5,189,475

                  • +0.01%

                  • 2.97

                  • OZ Management LLC

                  •  

                    3,180,702

                  • +20.71%

                  • 1.82

                  • OppenheimerFunds, Inc.

                  •  

                    3,108,859

                  • +8.62%

                  • 1.78

                  • AllianceBernstein LP

                  •  

                    3,020,112

                  • +133.82%

                  • 1.73

                  • T. Rowe Price Associates, Inc.

                  •  

                    2,701,642

                  • +5.20%

                  • 1.55

                  • JANA Partners LLC

                  •  

                    2,654,328

                  • +194.31%

                  • 1.52

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Speculative Growth

                  Style

                  Large Growth

                  Actavis plc, formerly known as Actavis Limited was incorporated in Ireland on May 16, 2013. It is a integrated specialty pharmaceutical company engaged in development, manufacturing, marketing, sale and distribution of generic, brand...moreed generic, brand name, biosimilar and over-the-counter pharmaceutical products. It also develop and out-license generic pharmaceutical products mainly in Europe through its Medis third-party business. The operates in three segments, Actavis Pharma, Actavis Specialty Brands and Anda Distribution. The Actavis Pharma segment includes off-patent pharmaceutical products that are therapeutically equivalent to proprietary products. The Actavis Specialty Brands segment includes patent-protected products and certain trademarked off-patent products that the Company sells and mark...moreets as brand pharmaceutical products. The Anda Distribution segment distributes generic and brand pharmaceutical products manufactured by third parties, as well as by the Company, primarily to independent pharmacies, pharmacy chains, pharmacy buying groups and physicians’ offices. It is subject to extensive, complex and evolving regulation by the federal government, principally the FDA, and to a lesser extent, by the U.S. Drug Enforcement Administration Occupational Safety and Health Administration and state government agencies, as well as by various regulatory agencies in foreign countries where its products or product candidates are being manufactured and/or marketed. The Federal Food, Drug and Cosmetic Act, the Controlled Substances Act and other federal statutes and regulations govern or influence the testing, manufacturing, packing, labeling, storing, record keeping, safety, approval, advertising, promotion, sale and distribution of its products.lessless

                  Key People

                  Brent Saunders

                  Director/President, Subsidiary/CEO, Subsidiary

                  Paul M. Bisaro

                  Chairman of the Board/Chairman of the Board, Subsidiary/Director

                  R. Todd Joyce

                  CFO

                  David A. Buchen

                  Executive VP, Divisional

                  William Meury

                  Executive VP, Divisional

                  • Actavis PLC

                  • 1 Grand Canal Square

                  • Dublin 2, 98-1114402

                  • IRL.Map

                  • Phone: +862 261-7000

                  • Fax: -

                  • actavis.com

                  Incorporated

                  2013

                  Employees

                  19,200

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: